LataMed AI (LMED) Notes Payables (2023 - 2026)

LataMed AI (LMED) has 4 years of Notes Payables data on file, last reported at $300688.0 in Q1 2026.

• For the quarter ending Q1 2026, Notes Payables rose 27.56% year-over-year to $300688.0; the trailing twelve-month figure through Mar 2026 stood at $300688.0 (up 27.56% YoY), and the FY2025 full-year result was $272304.0, up 25.65% from the prior year.
• Notes Payables climbed to $300688.0 in Q1 2026, from $272304.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $300688.0 in Q1 2026 to a low of $149879.0 in Q4 2023.
• A 4-year average of $232426.7 and a median of $235728.0 in 2025 frame the typical range for Notes Payables.
• Across the five-year window, Notes Payables jumped 44.59% in 2024 and advanced 25.65% in 2025, its largest moves.
• Tracing LMED's Notes Payables over 4 years: stood at $149879.0 in 2023, then soared by 44.59% to $216713.0 in 2024, then rose by 25.65% to $272304.0 in 2025, then climbed by 10.42% to $300688.0 in 2026.
• Business Quant data shows LMED's Notes Payables at $300688.0 in Q1 2026, $272304.0 in Q4 2025, and $264414.0 in Q3 2025.